Chemo-immunotherapy before and after surgery for peritoneal metastases of large bowel cancer
Recruiting
- Conditions
- Colorectal cancer with isolated peritoneal metastases
- Registration Number
- NL-OMON21182
- Lead Sponsor
- Catharina HospitalMichelangelolaan 25623 EJ, EindhovenThe Netherlands
- Brief Summary
Rovers KP, Simkens GA, Punt CJ, et al. Perioperative systemic therapy for resectable colorectal peritoneal metastases: sufficient evidence for its widespread use? A critical systematic review. Crit Rec Oncol Hematol. 2017;114:53-62.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 358
Inclusion Criteria
Eligible patients are adults who have:
•a World Health Organisation (WHO) performance status of ≤1;
Exclusion Criteria
Patients are excluded in case of any comorbidity or condition that prevents safe administration of the planned perioperative systemic therapy, determined by the treating medical oncologist, e.g.:
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method